TPW 2.16 Clinical Predictors of Non-Resolution after Gastrografin Challenge in Adhesional Small Bowel Obstruction

Clicks: 20
ID: 324101
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #289 of 432 articles by views in the british journal of surgery

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 432 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Aims Band adhesions remain the leading cause of small bowel obstruction (SBO) in adults. Non-operative management is the initial approach and succeeds in most cases. Gastrografin (Diatrizoate), a water-soluble contrast medium, aids resolution through its osmotic effect on the bowel. The aim of this study is to assess Gastrografin’s effectiveness and predictors of non-resolution in adhesional SBO. Methods This retrospective study, conducted at Mid and South Essex NHS Foundation Trust (January 2020–December 2024), included patients ≥ 16 years with CT-confirmed adhesional SBO who received 100 ml Gastrografin (orally or via nasogastric tube), followed by abdominal X-ray at 12 hours. Exclusions included non-adhesional causes of SBO, Gastrografin given only for diagnosis, contraindications to non-operative management, and incomplete data. Results A total of 271 patients (median age 74 years; 139 males, 132 females) were analysed. Median hospital stay was 10 days (range 0–159), with mean Charlson Comorbidity Index of 5.9. Adhesions were linked to prior colorectal surgery (41.0%), gynaecological surgery (10.7%), or no documented prior surgery (24.0%); 21.0% had previous SBO admissions. Contrast reached the colon in 59.4%, and clinical resolution occurred in 64.9%. Of 95 non-resolvers, 77.9% required surgery (26.3% with bowel resection). Only 10.5% of failures had prior SBO admissions, while 70.5% showed no colonic contrast at 12 hours. Conclusions Age, Charlson Comorbidity Index, and previous SBO admissions did not predict success. However, absence of contrast in the colon on X-ray 12 hours post-Gastrografin administration was a strong predictor of non-resolution and likely need for operative intervention.
Reference Key
openalex_W7172499678 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Andrew Chiagozie Ekwesianya, Jessie Abernethy, Wan Ko, Hayah Faridi, Wing Yan Chan, Abraham Ayantunde
Are you one of these authors? Claim your profile
Journal the british journal of surgery
Year 2026
DOI
10.1093/bjs/znag087.314
URL
https://doi.org/10.1093/bjs/znag087.314
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.